Evidence map›Paper›PMID 37128459›Full record

ArticleAMIA ... Annual Symposium proceedings. AMIA Symposium2022

Learning Clinical Concepts for Predicting Risk of Progression to Severe COVID-19.

Helen Zhou, Cheng Cheng, Kelly J Shields, Gursimran Kochhar, Tariq Cheema, Zachary C Lipton, Jeremy C Weiss

Open access · greenAbstract read
In one paragraph

Article in AMIA ... Annual Symposium proceedings. AMIA Symposium, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Helen ZhouCarnegie Mellon University, Pittsburgh, PA.
Cheng ChengCarnegie Mellon University, Pittsburgh, PA.
Kelly J ShieldsHighmark Health Enterprise Data & Analytics, Data Science R&D.
Gursimran KochharAllegheny Health Network, Pittsburgh, PA.
Tariq CheemaAllegheny Health Network, Pittsburgh, PA.
Zachary C LiptonCarnegie Mellon University, Pittsburgh, PA.
Jeremy C WeissCarnegie Mellon University, Pittsburgh, PA.
Carnegie Mellon University · USAllegheny Health Network · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With COVID-19 now pervasive, identification of high-risk individuals is crucial. Using data from a major healthcare provider in Southwestern Pennsylvania, we develop survival models predicting severe COVID-19 progression. In this endeavor, we face a tradeoff between more accurate models relying on many features and less accurate models relying on a few features aligned with clinician intuition. Complicating matters, many EHR features tend to be under-coded degrading the accuracy of smaller models. In this study we develop two sets of high-performance risk scores: (i) an unconstrained model built from all available features; and (ii) a pipeline that learns a small set of clinical concepts before training a risk predictor. Learned concepts boost performance over the corresponding features (C-index 0.858 vs. 0.844) and demonstrate improvements over (i) when evaluated out-of-sample (subsequent time periods). Our models outperform previous works (C-index 0.844-0.872 vs. 0.598-0.810).

Indexed as

COVID-19HumansMachine LearningPennsylvaniaRisk Factors

Identifiers

PMID37128459
PMCPMC10148297
OpenAlexW4293789303

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.